DOTA-BIM-23014:DOTA-Lanreotide

英語别名:: DOTA-Lanreotide;DOTA-Lanreotide acetate;DOTA-BIM-23014:DOTA-Lanreotide;L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-Lcysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-Lcysteinyl-,cyclic (2)-disulfide;L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide;L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 → 7) disulfide

物理性質

安全性情報

用途語

生産企業 2

DOTA-BIM-23014:DOTA-Lanreotide 物理性質

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入

Colourless to off-white lyophilised powder

Global( 2)Suppliers

名前	電話番号	電子メール	国籍	製品カタログ	優位度
Creative Peptides		info@creative-peptides.com	United States	6084	56

3-(2-ナフタレニル)-D-Ala-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2 テトラキセタン

213187-44-1
DOTA-BIM-23014:DOTA-Lanreotide
L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 → 7) disulfide
DOTA-Lanreotide
DOTA-Lanreotide acetate
L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-Lcysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-Lcysteinyl-,cyclic (2)-disulfide
L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide